It started with a belief

Octapharma was founded 40 years ago to provide hemophilia patients with a safer, higher-quality factor VIII (FVIII) concentrate.

News & stories

Check out our latest stories

Octapharma USA: FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD

Octapharma USA Presents Factor Concentrates for Perioperative Bleeding Symposium for ASA Annual Meeting Attendees

Heroes in the Fight: Octapharma To Be Honored for Myositis Research at TMA Annual Patient Conference

Octapharma's Prothrombin Complex Concentrate, Balfaxar®, Receives FDA Approval For Warfarin Reversal in Urgent Surgery & Invasive Procedures

Patient engagement

Octapharma takes an active role in our community

We sponsor and support organizations worldwide.

Learn how we engage with patients

Our products

Products

Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders.